KR100678864B1 - 천궁 추출물 및 카르니틴을 유효성분으로 함유하는 피부미백용 화장료 조성물 - Google Patents
천궁 추출물 및 카르니틴을 유효성분으로 함유하는 피부미백용 화장료 조성물 Download PDFInfo
- Publication number
- KR100678864B1 KR100678864B1 KR1020050079801A KR20050079801A KR100678864B1 KR 100678864 B1 KR100678864 B1 KR 100678864B1 KR 1020050079801 A KR1020050079801 A KR 1020050079801A KR 20050079801 A KR20050079801 A KR 20050079801A KR 100678864 B1 KR100678864 B1 KR 100678864B1
- Authority
- KR
- South Korea
- Prior art keywords
- carnitine
- extract
- cosmetic composition
- skin
- skin whitening
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 66
- 229960004203 carnitine Drugs 0.000 title claims abstract description 44
- 239000002537 cosmetic Substances 0.000 title claims abstract description 41
- 230000002087 whitening effect Effects 0.000 title claims abstract description 31
- 239000004480 active ingredient Substances 0.000 title claims abstract description 21
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 title claims abstract 6
- 238000009472 formulation Methods 0.000 claims abstract description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 28
- 239000006071 cream Substances 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 239000000843 powder Substances 0.000 claims description 11
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- 239000006210 lotion Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 239000000839 emulsion Substances 0.000 claims description 5
- 239000007921 spray Substances 0.000 claims description 5
- 229940058015 1,3-butylene glycol Drugs 0.000 claims description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 4
- 239000000499 gel Substances 0.000 claims description 3
- 239000006072 paste Substances 0.000 claims description 3
- 239000004094 surface-active agent Substances 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 2
- 239000000344 soap Substances 0.000 claims description 2
- 239000000243 solution Substances 0.000 claims description 2
- 206010040880 Skin irritation Diseases 0.000 abstract description 11
- 231100000475 skin irritation Toxicity 0.000 abstract description 11
- 230000036556 skin irritation Effects 0.000 abstract description 11
- 102000003425 Tyrosinase Human genes 0.000 abstract description 4
- 108060008724 Tyrosinase Proteins 0.000 abstract description 4
- 230000002195 synergetic effect Effects 0.000 abstract description 4
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 38
- 210000003491 skin Anatomy 0.000 description 26
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 21
- 230000000052 comparative effect Effects 0.000 description 19
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- -1 pack Substances 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 206010015150 Erythema Diseases 0.000 description 5
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 5
- 229920002125 Sokalan® Polymers 0.000 description 5
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 231100000321 erythema Toxicity 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 5
- 230000002335 preservative effect Effects 0.000 description 5
- 210000004291 uterus Anatomy 0.000 description 5
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 4
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 4
- 102000011782 Keratins Human genes 0.000 description 4
- 108010076876 Keratins Proteins 0.000 description 4
- 239000000637 Melanocyte-Stimulating Hormone Substances 0.000 description 4
- 108010007013 Melanocyte-Stimulating Hormones Proteins 0.000 description 4
- 229920001214 Polysorbate 60 Polymers 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000008099 melanin synthesis Effects 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 4
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 4
- 229940113124 polysorbate 60 Drugs 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 102400000686 Endothelin-1 Human genes 0.000 description 3
- 101800004490 Endothelin-1 Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 150000001261 hydroxy acids Chemical class 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 231100000430 skin reaction Toxicity 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical group C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010033733 Papule Diseases 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010040914 Skin reaction Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- XTKDAFGWCDAMPY-UHFFFAOYSA-N azaperone Chemical compound C1=CC(F)=CC=C1C(=O)CCCN1CCN(C=2N=CC=CC=2)CC1 XTKDAFGWCDAMPY-UHFFFAOYSA-N 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 238000004299 exfoliation Methods 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 230000035483 skin reaction Effects 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- WTFUTSCZYYCBAY-SXBRIOAWSA-N 6-[(E)-C-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-N-hydroxycarbonimidoyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C/C(=N/O)/C1=CC2=C(NC(O2)=O)C=C1 WTFUTSCZYYCBAY-SXBRIOAWSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 208000035484 Cellulite Diseases 0.000 description 1
- 241000212948 Cnidium Species 0.000 description 1
- 241000533367 Cnidium officinale Species 0.000 description 1
- 241000557626 Corvus corax Species 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000019687 Lamb Nutrition 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 102400000740 Melanocyte-stimulating hormone alpha Human genes 0.000 description 1
- 101710200814 Melanotropin alpha Proteins 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010049752 Peau d'orange Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229940079894 benzophenone-9 Drugs 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000036232 cellulite Effects 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 208000016252 change in skin color Diseases 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- QDCHWIWENYCPIL-UHFFFAOYSA-L disodium;4-hydroxy-5-(2-hydroxy-4-methoxy-5-sulfonatobenzoyl)-2-methoxybenzenesulfonate Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC(S([O-])(=O)=O)=C(OC)C=C1O QDCHWIWENYCPIL-UHFFFAOYSA-L 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 210000002780 melanosome Anatomy 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000013081 microcrystal Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000020989 red meat Nutrition 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000008491 skin homeostasis Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 230000007332 vesicle formation Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- WHNFPRLDDSXQCL-UAZQEYIDSA-N α-msh Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CO)NC(C)=O)C1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UAZQEYIDSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/70—Biological properties of the composition as a whole
- A61K2800/72—Hypo-allergenic
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cosmetics (AREA)
Abstract
Description
구분 | 함량 (중량%) | |||||
성분 | 실시예 | 비교예1 | 비교예2 | 비교예3 | 비교예4 | 비교예5 |
천궁 추출물 | 4.0 | - | 4.0 | - | - | - |
카르니틴 | 1.0 | - | - | 1.0 | - | - |
락트산 | - | - | - | - | 1.0 | - |
글리콜산 | - | - | - | - | - | 1.0 |
부틸렌글리콜 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 |
프로필렌글리콜 | 6.0 | 6.0 | 6.0 | 6.0 | 6.0 | 6.0 |
카르복시비닐폴리머 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
밀납 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 |
바셀린 | 7.0 | 7.0 | 7.0 | 7.0 | 7.0 | 7.0 |
폴리솔베이트 60 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 |
솔비탄세스퀴올레이트 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 |
스쿠알란 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 |
유동파라핀 | 10.0 | 10.0 | 10.0 | 10.0 | 10.0 | 10.0 |
트리에탄올아민 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
토코페릴아세테이트 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
향료, 방부제 | 미량 | 미량 | 미량 | 미량 | 미량 | 미량 |
정제수 | 잔량 | 잔량 | 잔량 | 잔량 | 잔량 | 잔량 |
합계 | 100 | 100 | 100 | 100 | 100 | 100 |
구분 | 실시예 | 비교예 1 | 비교예 2 | 비교예 3 |
ΔL 값 | 4.53 | 0.41 | 1.53 | 1.92 |
기호 | 점수 | 평가기준 |
- | 0 | 무반응, 정상 피부 |
± | 0.5 | 희미한 또는 가벼운 홍반 |
+ | 1.0 | 경계가 뚜렷하나 약한 홍반, 부종 및 구진 |
++ | 2.0 | 뚜렷한 홍반, 구진 및 소수포 |
+++ | 3.0 | 심한 홍반 및 소포형성 |
++++ | 6.0 | 대수포 형성 |
시험 물질 | 24 시간 | 48 시간 | 평균 피부 반응도 (n=20) |
± + ++ | ± + ++ | ||
실시예 | 1 1 - | 1 - - | 0.83 |
비교예 1 | 1 - - | 1 - - | 0.42 |
비교예 3 | 1 1 - | 1 - - | 0.63 |
비교예 4 | 5 4 - | 3 2 - | 4.71 |
비교예 5 | 4 4 - | 3 1 - | 3.96 |
보존 조건 | 실시예 | 비교예 1 | 비교예 3 | |
4℃ | 1주일 | 0 | 0 | 0 |
1개월 | 0 | 0 | 0 | |
6개월 | 0 | 0 | 0 | |
45℃ | 1주일 | 0 | 0 | 0 |
1개월 | 0 | 0 | 0 | |
6개월 | 0 | 0 | X | |
50℃ | 1주일 | 0 | 0 | 0 |
1개월 | 0 | 0 | 0 | |
6개월 | 0 | 0 | X | |
Cycle | 1주일 | 0 | 0 | 0 |
1개월 | 0 | 0 | X | |
6개월 | 0 | 0 | X | |
실온 | 1주일 | 0 | 0 | 0 |
1개월 | 0 | 0 | 0 | |
6개월 | 0 | 0 | 0 |
성분 | 함량 (중량%) |
천궁 추출물 | 4.0 |
카르니틴 | 1.0 |
1,3-부틸렌글리콜 | 6.0 |
글리세린 | 4.0 |
올레일알콜 | 0.1 |
폴리솔베이트 20 | 0.5 |
에탄올 | 15.0 |
벤조페논-9 | 0.05 |
향, 방부제 | 미량 |
정제수 | 잔량 |
성분 | 함량 (중량%) |
천궁 추출물 | 4.0 |
카르니틴 | 1.0 |
프로필렌글리콜 | 6.0 |
글리세린 | 4.0 |
트리에탄올아민 | 1.2 |
토코페릴아세테이트 | 3.0 |
유동 파라핀 | 5.0 |
스쿠알란 | 3.0 |
마카다미아너트오일 | 2.0 |
폴리솔베이트 60 | 1.5 |
솔비탄세스퀴올레이트 | 1.0 |
카르복시비닐 폴리머 | 1.0 |
향, 방부제 | 미량 |
정제수 | 잔량 |
성분 | 함량 (중량%) |
천궁 추출물 | 4.0 |
카르니틴 | 1.0 |
바셀린 | 7.0 |
유동파라핀 | 10.0 |
밀납 | 2.0 |
폴리솔베이트 60 | 2.0 |
솔비탄세스퀴올레이트 | 2.5 |
스쿠알란 | 3.0 |
프로필렌글리콜 | 6.0 |
글리세린 | 4.0 |
트리에탄올아민 | 0.5 |
카르복시비닐폴리머 | 0.5 |
토코페릴아세테이트 | 0.1 |
향, 방부제 | 미량 |
정제수 | 잔량 |
성분 | 함량 (중량%) |
천궁 추출물 | 4.0 |
카르니틴 | 1.0 |
프로필렌글리콜 | 6.0 |
글리세린 | 4.0 |
트리에탄올아민 | 0.5 |
밀납 | 2.0 |
토코페릴아세테이트 | 0.1 |
폴리솔베이트 60 | 3.0 |
솔비탄세스퀴올레이트 | 2.5 |
세테아릴알콜 | 2.0 |
유동파라핀 | 30.0 |
카르복시비닐폴리머 | 0.5 |
향, 방부제 | 미량 |
정제수 | 잔량 |
성분 | 함량 (중량%) |
천궁 추출물 | 4.0 |
카르니틴 | 1.0 |
프로필렌글리콜 | 2.0 |
글리세린 | 4.0 |
카르복시비닐폴리머 | 0.3 |
에탄올 | 7.0 |
피이지-40 히드로게비이티드 캐스터 오일 | 0.8 |
트리에탄올아민 | 0.3 |
향, 방부제 | 미량 |
정제수 | 잔량 |
Claims (5)
- 천궁 추출물 및 카르니틴을 유효성분으로 함유하는 피부 미백용 화장료 조성물.
- 제 1 항에 있어서, 상기 천궁 추출물의 함량은 화장료 조성물 전체 중량의 0.01-10.0 중량%인 것을 특징으로 하는 피부 미백용 화장료 조성물.
- 제 1 항에 있어서, 상기 카르니틴의 함량은 화장료 조성물 전체 중량의 0.01-10.0 중량%인 것을 특징으로 하는 피부 미백용 화장료 조성물.
- 제 1 항에 있어서, 상기 천궁 추출물은 물, 탄소수 1-4개의 무수 또는 함수 저급 알코올, 아세톤, 에틸아세테이트, 부틸아세테이트 및 1,3-부틸렌 글리콜로 구성된 군으로부터 선택되는 용매를 사용하여 추출된 것을 특징으로 하는 피부 미백용 화장료 조성물.
- 제 1 항에 있어서, 상기 화장료 조성물은 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클린싱, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이로 구성된 군으로부터 선택되는 제형을 갖는 것을 특징으로 하는 피부 미백용 화장료 조성물.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050079801A KR100678864B1 (ko) | 2005-08-30 | 2005-08-30 | 천궁 추출물 및 카르니틴을 유효성분으로 함유하는 피부미백용 화장료 조성물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050079801A KR100678864B1 (ko) | 2005-08-30 | 2005-08-30 | 천궁 추출물 및 카르니틴을 유효성분으로 함유하는 피부미백용 화장료 조성물 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100678864B1 true KR100678864B1 (ko) | 2007-02-05 |
Family
ID=38105412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020050079801A Expired - Fee Related KR100678864B1 (ko) | 2005-08-30 | 2005-08-30 | 천궁 추출물 및 카르니틴을 유효성분으로 함유하는 피부미백용 화장료 조성물 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100678864B1 (ko) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101017586B1 (ko) | 2008-11-28 | 2011-02-28 | (주)아모레퍼시픽 | 피부 미백용 화장료 조성물 |
WO2019112129A1 (ko) * | 2017-12-04 | 2019-06-13 | 주식회사 엘지생활건강 | 피부 각질 박리 촉진용 화장용 조성물 |
KR20200043283A (ko) * | 2018-10-17 | 2020-04-27 | 주식회사 엘지생활건강 | 피부 각질 박리 촉진용 화장료 조성물 |
CN112423730A (zh) * | 2018-07-17 | 2021-02-26 | 株式会社Lg生活健康 | 角质剥离增强用化妆料组合物 |
EP3824872A4 (en) * | 2018-07-17 | 2022-04-27 | LG Household & Health Care Ltd. | COSMETIC COMPOSITION TO PROMOTE SKIN PEELING |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08291039A (ja) * | 1995-04-18 | 1996-11-05 | Kanebo Ltd | 美白化粧料 |
KR20030087236A (ko) * | 2002-05-08 | 2003-11-14 | 주식회사 코리아나화장품 | 천궁 추출물을 포함하는 피부 미백용 화장료 조성물 |
KR20040037521A (ko) * | 2002-10-29 | 2004-05-07 | 주식회사 코리아나화장품 | 생큐노라이드 a를 포함하는 피부 미백용 화장료 조성물 |
JP2005170834A (ja) | 2003-12-10 | 2005-06-30 | Taiyo Yakuhin Kogyo Kk | 皮膚改善製剤 |
-
2005
- 2005-08-30 KR KR1020050079801A patent/KR100678864B1/ko not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08291039A (ja) * | 1995-04-18 | 1996-11-05 | Kanebo Ltd | 美白化粧料 |
KR20030087236A (ko) * | 2002-05-08 | 2003-11-14 | 주식회사 코리아나화장품 | 천궁 추출물을 포함하는 피부 미백용 화장료 조성물 |
KR20040037521A (ko) * | 2002-10-29 | 2004-05-07 | 주식회사 코리아나화장품 | 생큐노라이드 a를 포함하는 피부 미백용 화장료 조성물 |
JP2005170834A (ja) | 2003-12-10 | 2005-06-30 | Taiyo Yakuhin Kogyo Kk | 皮膚改善製剤 |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101017586B1 (ko) | 2008-11-28 | 2011-02-28 | (주)아모레퍼시픽 | 피부 미백용 화장료 조성물 |
WO2019112129A1 (ko) * | 2017-12-04 | 2019-06-13 | 주식회사 엘지생활건강 | 피부 각질 박리 촉진용 화장용 조성물 |
CN112423730A (zh) * | 2018-07-17 | 2021-02-26 | 株式会社Lg生活健康 | 角质剥离增强用化妆料组合物 |
EP3824872A4 (en) * | 2018-07-17 | 2022-04-27 | LG Household & Health Care Ltd. | COSMETIC COMPOSITION TO PROMOTE SKIN PEELING |
CN112423730B (zh) * | 2018-07-17 | 2024-10-22 | 株式会社Lg生活健康 | 角质剥离增强用化妆料组合物 |
KR20200043283A (ko) * | 2018-10-17 | 2020-04-27 | 주식회사 엘지생활건강 | 피부 각질 박리 촉진용 화장료 조성물 |
KR102771004B1 (ko) | 2018-10-17 | 2025-02-21 | 주식회사 엘지생활건강 | 피부 각질 박리 촉진용 화장료 조성물 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101176528B1 (ko) | 배암차즈기 추출물을 유효성분으로 함유하는 화장료 조성물 | |
KR20160123732A (ko) | 아티초크 추출물 및 콜리플라워 추출물을 유효성분으로 함유하는 화장료 조성물 | |
KR100874115B1 (ko) | 백리향 추출물을 유효성분으로 함유하는 화장료 조성물 | |
KR101131574B1 (ko) | 피부 미백용 조성물 | |
KR100920896B1 (ko) | 블루로터스 및 테트라하이드로커큐민을 유효성분으로함유하는 피부 미백용 화장료 조성물 | |
KR20160120355A (ko) | 피부-윤광 화장품 조성물 | |
KR102226179B1 (ko) | 항노화 화장료 조성물 | |
KR100678864B1 (ko) | 천궁 추출물 및 카르니틴을 유효성분으로 함유하는 피부미백용 화장료 조성물 | |
KR100513902B1 (ko) | 장뇌삼 추출물을 포함하는 피부 노화 방지용 화장료 조성물 | |
KR102044935B1 (ko) | 병아리콩 추출물을 포함하는 피부 미백용 또는 피부 보습용 화장료 조성물 | |
KR20210060801A (ko) | 식물 복합 발효물을 유효성분으로 포함하는 항노화 화장료 조성물 | |
KR20120036417A (ko) | 참다시마 추출물을 유효성분으로 함유하는 피부 미백용 화장료 조성물 | |
KR20090055079A (ko) | 야생 참마 추출물을 함유하는 피부노화 방지용 화장료조성물 | |
KR102479095B1 (ko) | 때죽나무 추출물을 함유하는 미백용 화장료 조성물 | |
KR100744947B1 (ko) | 천궁 추출물 및 프로테아제를 유효성분으로 함유하는 피부미백용 화장료 조성물 | |
KR100678865B1 (ko) | 상지 추출물 및 카르니틴을 유효성분으로 함유하는 피부미백용 화장료 조성물 | |
KR20130099610A (ko) | 고사리삼 추출물을 함유하는 피부 외용제 조성물 | |
KR101317433B1 (ko) | 지구자, 길경, 밀싹 및 세이지 추출물을 함유하는 미백 화장용 조성물 | |
KR100713556B1 (ko) | 천궁 추출물 및 헥사노일트리펩타이드를 유효성분으로함유하는 피부 미백용 화장료 조성물 | |
KR100713557B1 (ko) | 상지 추출물 및 헥사노일트리펩타이드를 유효성분으로함유하는 피부 미백용 화장료 조성물 | |
KR20140071716A (ko) | 으름덩굴 추출물을 유효성분으로 함유하는 화장료 조성물 | |
KR101664878B1 (ko) | 삼채 분획물을 유효성분으로 함유하는 화장료 조성물 | |
KR100515951B1 (ko) | 괴화 추출물 및 알부틴을 포함하는 미백 화장료 조성물 | |
KR101844980B1 (ko) | 제주산버들 추출물을 함유하는 피부 외용제 조성물 | |
KR101195576B1 (ko) | 파피루스 추출물을 함유하는 피부 미백 화장료 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20050830 |
|
PA0201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20061030 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20070130 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20070130 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20091224 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20100902 Start annual number: 5 End annual number: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20110916 Start annual number: 6 End annual number: 6 |
|
FPAY | Annual fee payment |
Payment date: 20130111 Year of fee payment: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20130111 Start annual number: 7 End annual number: 7 |
|
FPAY | Annual fee payment |
Payment date: 20131127 Year of fee payment: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20131127 Start annual number: 8 End annual number: 8 |
|
FPAY | Annual fee payment |
Payment date: 20150112 Year of fee payment: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20150112 Start annual number: 9 End annual number: 9 |
|
FPAY | Annual fee payment |
Payment date: 20151211 Year of fee payment: 10 |
|
PR1001 | Payment of annual fee |
Payment date: 20151211 Start annual number: 10 End annual number: 10 |
|
FPAY | Annual fee payment |
Payment date: 20161227 Year of fee payment: 11 |
|
PR1001 | Payment of annual fee |
Payment date: 20161227 Start annual number: 11 End annual number: 11 |
|
FPAY | Annual fee payment |
Payment date: 20190109 Year of fee payment: 13 |
|
PR1001 | Payment of annual fee |
Payment date: 20190109 Start annual number: 13 End annual number: 13 |
|
FPAY | Annual fee payment |
Payment date: 20191226 Year of fee payment: 14 |
|
PR1001 | Payment of annual fee |
Payment date: 20191226 Start annual number: 14 End annual number: 14 |
|
PR1001 | Payment of annual fee |
Payment date: 20201222 Start annual number: 15 End annual number: 15 |
|
PR1001 | Payment of annual fee |
Payment date: 20220127 Start annual number: 16 End annual number: 16 |
|
PC1903 | Unpaid annual fee |
Termination category: Default of registration fee Termination date: 20241110 |